Oruka Therapeutics, Inc. (ORKA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 43K | 28K | 0 | 0 | 0 | 0 | 0 | 0 | 19K | 28K | 28K | 27K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -43K | -28K | 0 | 0 | 0 | 0 | 0 | 0 | -19K | -28K | -28K | -27K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 100% | - | - | - | - | -64.71% | -75% | -3.85% |
| Operating Expenses | 36.39M | 34.4M | 34.1M | 28.43M | 25.09M | 38.33M | 29.45M | 21.49M | 2.46M | 3.25M | 5.65M | 4.69M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 7.25M | 6.76M | 5.12M | 4.34M | 5.16M | 6M | 3.76M | 2.82M | 1.67M | 1.07M | 1.71M | 1.25M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 29.14M | 27.64M | 28.99M | 24.09M | 19.93M | 32.33M | 25.69M | 18.67M | 165K | 2.18M | 3.94M | 3.44M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 628K | 0 | 0 | 0 |
| Operating Income | -36.43M | -34.43M | -34.1M | -28.43M | -25.09M | -38.33M | -29.45M | -21.49M | -2.48M | -3.28M | -5.68M | -4.72M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -45.24% | 10.17% | -15.81% | -32.27% | -910.72% | - | - | - | - | 20.11% | -10.81% | -136.98% |
| EBITDA | -36.39M | -34.4M | -34.09M | -28.41M | -25.07M | -38.31M | -28.12M | -22.24M | -2.46M | -3.25M | -5.65M | -4.69M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -45.16% | 10.2% | -21.22% | -27.73% | -917.86% | - | - | - | - | 20.47% | -10.61% | -138.75% |
| D&A (Non-Cash Add-back) | 43K | 28K | 20K | 19K | 16K | 18.45K | 0 | 0 | 19K | 28K | 28K | 27K |
| EBIT | -36.43M | -34.43M | -30.28M | -24.57M | -21M | -37.46M | -28.12M | -22.24M | -2.01M | -3.27M | -5.68M | -4.71M |
| Net Interest Income | 4.61M | 4.85M | 3.83M | 3.86M | 4.09M | 4.53M | 826K | 444K | 473K | 0 | 0 | 0 |
| Interest Income | 4.61M | 4.85M | 3.83M | 3.86M | 4.09M | 4.53M | 1.33M | 444K | 473K | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 504K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.61M | 4.85M | 3.83M | 3.85M | 4.09M | 4.94M | 826K | -750K | 473K | 5K | 4K | 4K |
| Pretax Income | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -33.39M | -28.62M | -22.24M | -2.01M | -3.27M | -5.68M | -4.71M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -33.39M | -28.62M | -22.24M | -2.01M | -3.27M | -5.68M | -4.71M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -51.53% | 11.41% | -5.78% | -10.48% | -945.25% | - | - | - | - | 20.2% | -10.75% | -136.66% |
| Net Income (Continuing) | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -33.39M | -28.62M | -22.24M | -2.01M | -3.27M | -5.68M | -4.71M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 | -0.24 | -2.72 | -4.73 | -3.92 |
| EPS Growth % | -16% | 64.94% | 63.87% | 55.38% | -108.33% | - | - | - | - | 31.66% | 26.55% | 0.76% |
| EPS (Basic) | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 | -0.24 | -2.72 | -4.73 | -3.92 |
| Diluted Shares Outstanding | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 1.2M | 1.2M | 1.2M |
| Basic Shares Outstanding | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 1.2M | 1.2M | 1.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |